PLYMOUTH, Minn.--(BUSINESS WIRE)--Rotation Medical Inc., a medical device company focused on developing new technologies to treat rotator cuff disease, today announced that the company’s president and chief executive officer, Martha Shadan, has been appointed to the board of directors of the Advanced Medical Technology Association (AdvaMed).
Shadan has served on the board of directors for AdvaMed’s Accel division, which is dedicated to the needs of smaller medical technology manufacturers, since 2015. She is also a member of the leadership circle for AdvaMed’s Women’s Executive Network (WEN), an initiative promoting and cultivating female executive leadership across the medical technology industry, and co-chairs the organization’s Physician Owned Companies Working Group.
“AdvaMed is pleased to have someone of Martha’s caliber on our Board of Directors,” said Scott Whitaker, president and CEO of AdvaMed. “Martha has three decades of industry experience, including senior leadership positions at Zimmer and Covidien prior to her nearly four years at the helm of Rotation Medical. The depth and breadth of knowledge that she brings to AdvaMed will help ensure that the entire ecosystem of medical technology is healthy and strong so we can continue our work to enhance the lives of patients worldwide. In addition, as a representative of our Accel Board, Martha will be a strong advocate for the unique needs of the association’s emerging members.”
AdvaMed is a trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world. It represents 80 percent of medical technology firms in the U.S. and acts as the common voice for companies producing medical devices, diagnostic products and health information systems.
“It is a tremendous honor to join industry leaders across the country as part of AdvaMed’s board of directors,” Shadan said. “Rotation Medical is proud to be part of an organization that improves the lives of patients around the world through innovation and growth in the med tech industry.”
Shadan joined Rotation Medical in 2013, bringing more than 30 years of marketing and commercialization expertise to her role as CEO. Under her leadership, the company’s sales for 2016 exceeded expectations by 30 percent, and it secured $12 million in series B financing to continue U.S. commercialization activities for the Rotation Medical Bioinductive Implant for rotator cuff tears. Cleared by the U.S. Food and Drug Administration in March 2014, the Bioinductive Implant helps tendons heal through the induction of new tissue growth. The collagen-based implant is about the size of a postage stamp and it is part of the Rotation Medical rotator cuff system, which also includes disposable instruments that allow the arthroscopic procedure to be performed easily and quickly.
About Rotation Medical
Rotation Medical Inc. was founded in 2009 and is committed to improving the treatment of rotator cuff disease with the Rotation Medical rotator cuff system, a breakthrough technology that has the potential to prevent rotator cuff disease progression and reduce re-tears by inducing the growth of new tendinous tissue. The company is privately held and funded by New Enterprise Associates (NEA), Life Sciences Partners (LSP) and Pappas Ventures. For more information, visit http://www.rotationmedical.com/.